Ascletis Pharma Inc. ( ASCLF) - Key Metrics
ASCLF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.31 | $0 | $0 |
| 2025Q4 | $0 | -$0.27 | -$0.21 | -$0.21 |
| 2025Q2 | $0 | -$0.09 | -$0.18 | -$0.18 |
| 2024Q4 | $0 | -$0.17 | -$0.14 | -$0.14 |
| 2024Q2 | $0 | -$0.13 | -$0.20 | -$0.20 |
ASCLF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -7.39 |
| 2025Q4 | 0% | -9.65 |
| 2025Q2 | 0% | -18.27 |
| 2024Q4 | 0% | -2.52 |
| 2024Q2 | 0% | -1.99 |
ASCLF
Price: $0.75
52 week price:
Earnings Per Share: -0.09 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 1.1 billion